Cargando…

Antiviral activity of ginsenosides against coxsackievirus B3, enterovirus 71, and human rhinovirus 3

BACKGROUND: Ginsenosides are the major components responsible for the biochemical and pharmacological actions of ginseng, and have been shown to have various biological activities. In this study, we investigated the antiviral activities of seven ginsenosides [protopanaxatriol (PT) type: Re, Rf, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Jae-Hyoung, Choi, Hwa-Jung, Song, Hyuk-Hwan, Hong, Eun-Hye, Lee, Bo-Ra, Oh, Sei-Ryang, Choi, Kwangman, Yeo, Sang-Gu, Lee, Yong-Pyo, Cho, Sungchan, Ko, Hyun-Jeong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4213867/ https://www.ncbi.nlm.nih.gov/pubmed/25378991 http://dx.doi.org/10.1016/j.jgr.2014.04.003

Ejemplares similares

Antiviral activity of micafungin against enterovirus 71
por: Kim, Chonsaeng, et al.
Publicado: (2016)

VP1 of Enterovirus 71 Protects Mice Against Enterovirus 71 and Coxsackievirus B3 in Lethal Challenge Experiment
por: Chen, Fang-Hong, et al.
Publicado: (2019)

Inhibitory Effects of Norwogonin, Oroxylin A, and Mosloflavone on Enterovirus 71
por: Choi, Hwa Jung, et al.
Publicado: (2016)

Antiviral Activity of Hederasaponin B from Hedera helix against Enterovirus 71 Subgenotypes C3 and C4a
por: Song, JaeHyoung, et al.
Publicado: (2014)

A Bivalent Inactivated Vaccine Prevents Enterovirus 71 and Coxsackievirus A16 Infections in the Mongolian Gerbil
por: Yi, Eun-Je, et al.
Publicado: (2023)

Antiviral Ability of Kalanchoe gracilis Leaf Extract against Enterovirus 71 and Coxsackievirus A16
por: Wang, Ching-Ying, et al.
Publicado: (2012)

Pyroptosis induced by enterovirus 71 and coxsackievirus B3 infection affects viral replication and host response
por: Wang, Yan, et al.
Publicado: (2018)

Transcriptome analysis following enterovirus 71 and coxsackievirus A16 infection in respiratory epithelial cells
por: Song, Jie, et al.
Publicado: (2020)

Seroepidemiology of human enterovirus71 and coxsackievirusA16 in Jiangsu province, China
por: Ji, Hong, et al.
Publicado: (2012)

Human enterovirus 71 subgenotype B3 lacks coxsackievirus A16-like neurovirulence in mice infection
por: Chan, Yoke-Fun, et al.
Publicado: (2005)

Protease 2A induces stress granule formation during coxsackievirus B3 and enterovirus 71 infections
por: Wu, Shuo, et al.
Publicado: (2014)

Novel Substituted Heteroaromatic Piperazine and Piperidine Derivatives as Inhibitors of Human Enterovirus 71 and Coxsackievirus A16
por: Zhang, Xian, et al.
Publicado: (2013)

Immunologic Characterization of Cytokine Responses to Enterovirus 71 and Coxsackievirus A16 Infection in Children
por: Zhang, Shu-Yan, et al.
Publicado: (2015)

Bioinformatics-based prediction of conformational epitopes for Enterovirus A71 and Coxsackievirus A16
por: Wang, Liping, et al.
Publicado: (2021)

Antiviral Activity of Chrysin Derivatives against Coxsackievirus B3 in vitro and in vivo
por: Song, Jae-Hyoung, et al.
Publicado: (2015)

Seroepidemiology of Coxsackievirus A6, Coxsackievirus A16, and Enterovirus 71 Infections among Children and Adolescents in Singapore, 2008-2010
por: Ang, Li Wei, et al.
Publicado: (2015)

Incorrect identification of recent Asian strains of Coxsackievirus A16 as human enterovirus 71: Improved primers for the specific detection of human enterovirus 71 by RT PCR
por: Perera, David, et al.
Publicado: (2004)

Seroepidemiology of human enterovirus71 and coxsackievirusA16 among children in Guangdong province, China
por: Li, Wei, et al.
Publicado: (2013)

Seroprevalence of Enterovirus A71 and Coxsackievirus A16 in Healthy People in Shandong Province, China
por: Wang, Jian-xing, et al.
Publicado: (2016)

Seroprevalence and Virologic Surveillance of Enterovirus 71 and Coxsackievirus A6, United Kingdom, 2006–2017
por: Kamau, Everlyn, et al.
Publicado: (2021)

Computational Screening of Newly Designed Compounds against Coxsackievirus A16 and Enterovirus A71
por: Sripattaraphan, Amita, et al.
Publicado: (2022)

Potent antiviral agents fail to elicit genetically-stable resistance mutations in either enterovirus 71 or Coxsackievirus A16
por: Kelly, James T., et al.
Publicado: (2015)

Antiviral activity of Lactobacillus reuteri Protectis against Coxsackievirus A and Enterovirus 71 infection in human skeletal muscle and colon cell lines
por: Ang, Lei Yin Emily, et al.
Publicado: (2016)

Detection of human enterovirus 71 and coxsackievirus A16 in children with hand, foot and mouth disease in China
por: CHEN, LING, et al.
Publicado: (2012)

Systematic Identification and Bioinformatic Analysis of MicroRNAs in Response to Infections of Coxsackievirus A16 and Enterovirus 71
por: Zhu, Zheng, et al.
Publicado: (2016)

Recommendations for the nomenclature of enteroviruses and rhinoviruses
por: Simmonds, P., et al.
Publicado: (2020)

Erratum to: Antiviral activity of Lactobacillus reuteri Protectis against Coxsackievirus A and Enterovirus 71 infection in human skeletal muscle and colon cell lines
por: Ang, Lei Yin Emily, et al.
Publicado: (2016)

Manassantin B shows antiviral activity against coxsackievirus B3 infection by activation of the STING/TBK-1/IRF3 signalling pathway
por: Song, Jae-Hyoung, et al.
Publicado: (2019)

Antivirals and vaccines for Enterovirus A71
por: Lin, Jing-Yi, et al.
Publicado: (2019)

Seroprevalence of coxsackievirus A6 and enterovirus A71 infection in humans: a systematic review and meta-analysis
por: Shi, Yingying, et al.
Publicado: (2023)

Molecular evolutionary dynamics of enterovirus A71, coxsackievirus A16 and coxsackievirus A6 causing hand, foot and mouth disease in Thailand, 2000–2022
por: Noisumdaeng, Pirom, et al.
Publicado: (2023)

Glycyrrhizic acid as the antiviral component of Glycyrrhiza uralensis Fisch. against coxsackievirus A16 and enterovirus 71 of hand foot and mouth disease
por: Wang, Jingjing, et al.
Publicado: (2013)

Receptors for enterovirus 71
por: Yamayoshi, Seiya, et al.
Publicado: (2014)

Development of a multiplex polymerase chain reaction assay for simultaneous identification of human enterovirus 71 and coxsackievirus A16
por: Thao, Nguyen Thi Thanh, et al.
Publicado: (2010)

Identification of Luteolin as Enterovirus 71 and Coxsackievirus A16 Inhibitors through Reporter Viruses and Cell Viability-Based Screening
por: Xu, Lin, et al.
Publicado: (2014)

Seroprevalence of Human Enterovirus 71 and Coxsackievirus A16 in Guangdong, China, in Pre- and Post-2010 HFMD Epidemic Period
por: Li, Wei, et al.
Publicado: (2013)

Development of stable, cold-adapted, temperature-sensitive/conditional lethal chimeric enterovirus A71 and coxsackievirus A16
por: Chua, Kaw Bing, et al.
Publicado: (2022)

Flavonoids as Antiviral Agents for Enterovirus A71 (EV-A71)
por: Lalani, Salima, et al.
Publicado: (2020)

Enterovirus 71 infection and neurological complications
por: Lee, Kyung Yeon
Publicado: (2016)

Rhinoviruses and Respiratory Enteroviruses: Not as Simple as ABC
por: Royston, Léna, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6e98r25u3nrad4fca8ssg2o134